25 XP   0   0   10

Alpine Immune Sciences Inc
Buy, Hold or Sell?

Let's analyse Alpine Immune Sciences Inc together

PenkeI guess you are interested in Alpine Immune Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alpine Immune Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Alpine Immune Sciences Inc

I send you an email if I find something interesting about Alpine Immune Sciences Inc.

Quick analysis of Alpine Immune Sciences Inc (30 sec.)










What can you expect buying and holding a share of Alpine Immune Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$5.00
Expected worth in 1 year
$14.06
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
$9.06
Return On Investment
14.0%

For what price can you sell your share?

Current Price per Share
$64.60
Expected price per share
$41.16 - $
How sure are you?
50%

1. Valuation of Alpine Immune Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$64.60

Intrinsic Value Per Share

$-25.65 - $-7.73

Total Value Per Share

$-20.64 - $-2.73

2. Growth of Alpine Immune Sciences Inc (5 min.)




Is Alpine Immune Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$327.9m$179.4m$148.5m45.3%

How much money is Alpine Immune Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$32.1m-$57.7m$25.5m79.5%
Net Profit Margin-54.7%-192.1%--

How much money comes from the company's main activities?

3. Financial Health of Alpine Immune Sciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#166 / 1007

Most Revenue
#250 / 1007

Most Profit
#514 / 1007

Most Efficient
#550 / 1007

What can you expect buying and holding a share of Alpine Immune Sciences Inc? (5 min.)

Welcome investor! Alpine Immune Sciences Inc's management wants to use your money to grow the business. In return you get a share of Alpine Immune Sciences Inc.

What can you expect buying and holding a share of Alpine Immune Sciences Inc?

First you should know what it really means to hold a share of Alpine Immune Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Alpine Immune Sciences Inc is $64.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alpine Immune Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alpine Immune Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.00. Based on the TTM, the Book Value Change Per Share is $2.27 per quarter. Based on the YOY, the Book Value Change Per Share is $0.89 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alpine Immune Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.49-0.8%-0.49-0.8%-0.88-1.4%-0.64-1.0%-0.49-0.8%
Usd Book Value Change Per Share2.273.5%2.273.5%0.891.4%0.861.3%0.641.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.273.5%2.273.5%0.891.4%0.861.3%0.641.0%
Usd Price Per Share19.06-19.06-7.35-11.34-8.16-
Price to Earnings Ratio-38.83--38.83--8.34--20.16--22.87-
Price-to-Total Gains Ratio8.41-8.41-8.23-8.15-7.21-
Price to Book Ratio3.81-3.81-2.69-7.17-5.93-
Price-to-Total Gains Ratio8.41-8.41-8.23-8.15-7.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share64.6
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.270.86
Usd Total Gains Per Share2.270.86
Gains per Quarter (15 shares)33.9812.97
Gains per Year (15 shares)135.9251.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1013612605242
20272262010494
304083980156146
405445340207198
506806700259250
608168060311302
709519420363354
80108710780415406
90122312140467458
100135913500519510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.00.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%7.04.00.063.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.011.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%7.04.00.063.6%

Fundamentals of Alpine Immune Sciences Inc

About Alpine Immune Sciences Inc

Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases. The company's product pipeline includes Povetacicept, a dual B cell cytokine antagonist, which is in Phase 2 clinical trial for the treatment of multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways that is in preclinical trial for the treatment of systemic lupus erythematosus. It is also developing RUBY-3 that has completed Phase 1 clinical trial for the treatment of glomerulonephritis; and RUBY-4, which has completed Phase 1 clinical trial for the treatment of cytopenias. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Fundamental data was last updated by Penke on 2024-05-02 09:58:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Alpine Immune Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alpine Immune Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -54.7% means that $-0.55 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alpine Immune Sciences Inc:

  • The MRQ is -54.7%. The company is making a huge loss. -2
  • The TTM is -54.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-54.7%TTM-54.7%0.0%
TTM-54.7%YOY-192.1%+137.5%
TTM-54.7%5Y-641.1%+586.4%
5Y-641.1%10Y-1,453.5%+812.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-54.7%-207.2%+152.5%
TTM-54.7%-218.5%+163.8%
YOY-192.1%-282.4%+90.3%
5Y-641.1%-432.2%-208.9%
10Y-1,453.5%-593.8%-859.7%
1.1.2. Return on Assets

Shows how efficient Alpine Immune Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • -8.4% Return on Assets means that Alpine Immune Sciences Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alpine Immune Sciences Inc:

  • The MRQ is -8.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.4%TTM-8.4%0.0%
TTM-8.4%YOY-20.1%+11.7%
TTM-8.4%5Y-29.3%+20.8%
5Y-29.3%10Y-35.1%+5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.4%-13.2%+4.8%
TTM-8.4%-12.6%+4.2%
YOY-20.1%-11.5%-8.6%
5Y-29.3%-13.7%-15.6%
10Y-35.1%-15.5%-19.6%
1.1.3. Return on Equity

Shows how efficient Alpine Immune Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • -9.8% Return on Equity means Alpine Immune Sciences Inc generated $-0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alpine Immune Sciences Inc:

  • The MRQ is -9.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-9.8%0.0%
TTM-9.8%YOY-32.2%+22.4%
TTM-9.8%5Y-54.6%+44.8%
5Y-54.6%10Y-44.9%-9.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-16.7%+6.9%
TTM-9.8%-15.8%+6.0%
YOY-32.2%-14.4%-17.8%
5Y-54.6%-19.0%-35.6%
10Y-44.9%-19.9%-25.0%

1.2. Operating Efficiency of Alpine Immune Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alpine Immune Sciences Inc is operating .

  • Measures how much profit Alpine Immune Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -75.2% means the company generated $-0.75  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alpine Immune Sciences Inc:

  • The MRQ is -75.2%. The company is operating very inefficient. -2
  • The TTM is -75.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-75.2%TTM-75.2%0.0%
TTM-75.2%YOY-193.4%+118.3%
TTM-75.2%5Y-658.7%+583.5%
5Y-658.7%10Y-1,492.9%+834.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.2%-286.5%+211.3%
TTM-75.2%-229.1%+153.9%
YOY-193.4%-288.4%+95.0%
5Y-658.7%-480.7%-178.0%
10Y-1,492.9%-624.7%-868.2%
1.2.2. Operating Ratio

Measures how efficient Alpine Immune Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.75 means that the operating costs are $1.75 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 1.752. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.752. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.752TTM1.7520.000
TTM1.752YOY2.954-1.202
TTM1.7525Y12.299-10.547
5Y12.29910Y23.056-10.757
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7523.231-1.479
TTM1.7523.307-1.555
YOY2.9543.774-0.820
5Y12.2995.667+6.632
10Y23.0567.558+15.498

1.3. Liquidity of Alpine Immune Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alpine Immune Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.86 means the company has $7.86 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 7.862. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.862. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.862TTM7.8620.000
TTM7.862YOY4.155+3.706
TTM7.8625Y4.449+3.413
5Y4.44910Y11.350-6.901
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8623.890+3.972
TTM7.8624.182+3.680
YOY4.1555.343-1.188
5Y4.4496.135-1.686
10Y11.3506.453+4.897
1.3.2. Quick Ratio

Measures if Alpine Immune Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 14.57 means the company can pay off $14.57 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 14.570. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.570. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.570TTM14.5700.000
TTM14.570YOY7.977+6.593
TTM14.5705Y7.687+6.883
5Y7.68710Y19.201-11.514
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.5703.528+11.042
TTM14.5704.059+10.511
YOY7.9775.390+2.587
5Y7.6876.138+1.549
10Y19.2016.488+12.713

1.4. Solvency of Alpine Immune Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alpine Immune Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alpine Immune Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Alpine Immune Sciences Inc assets are financed with 14.1% credit (debt) and the remaining percentage (100% - 14.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 0.141. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.141. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.141TTM0.1410.000
TTM0.141YOY0.374-0.233
TTM0.1415Y0.413-0.272
5Y0.41310Y0.403+0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1410.339-0.198
TTM0.1410.337-0.196
YOY0.3740.273+0.101
5Y0.4130.368+0.045
10Y0.4030.391+0.012
1.4.2. Debt to Equity Ratio

Measures if Alpine Immune Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.4% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alpine Immune Sciences Inc:

  • The MRQ is 0.164. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.164. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.164TTM0.1640.000
TTM0.164YOY0.598-0.434
TTM0.1645Y0.806-0.642
5Y0.80610Y0.451+0.355
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1640.388-0.224
TTM0.1640.403-0.239
YOY0.5980.342+0.256
5Y0.8060.432+0.374
10Y0.4510.461-0.010

2. Market Valuation of Alpine Immune Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Alpine Immune Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Alpine Immune Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of -38.83 means the investor is paying $-38.83 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alpine Immune Sciences Inc:

  • The EOD is -131.594. Based on the earnings, the company is expensive. -2
  • The MRQ is -38.826. Based on the earnings, the company is expensive. -2
  • The TTM is -38.826. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-131.594MRQ-38.826-92.767
MRQ-38.826TTM-38.8260.000
TTM-38.826YOY-8.342-30.484
TTM-38.8265Y-20.158-18.668
5Y-20.15810Y-22.865+2.707
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-131.594-2.249-129.345
MRQ-38.826-2.553-36.273
TTM-38.826-2.669-36.157
YOY-8.342-4.107-4.235
5Y-20.158-6.247-13.911
10Y-22.865-6.499-16.366
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alpine Immune Sciences Inc:

  • The EOD is -53.274. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.718. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.718. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-53.274MRQ-15.718-37.556
MRQ-15.718TTM-15.7180.000
TTM-15.718YOY-10.910-4.808
TTM-15.7185Y-12.894-2.824
5Y-12.89410Y-14.734+1.840
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-53.274-2.858-50.416
MRQ-15.718-3.288-12.430
TTM-15.718-3.552-12.166
YOY-10.910-5.560-5.350
5Y-12.894-8.326-4.568
10Y-14.734-8.881-5.853
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alpine Immune Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.81 means the investor is paying $3.81 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Alpine Immune Sciences Inc:

  • The EOD is 12.915. Based on the equity, the company is expensive. -2
  • The MRQ is 3.810. Based on the equity, the company is fair priced.
  • The TTM is 3.810. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD12.915MRQ3.810+9.104
MRQ3.810TTM3.8100.000
TTM3.810YOY2.686+1.125
TTM3.8105Y7.168-3.357
5Y7.16810Y5.928+1.240
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD12.9151.929+10.986
MRQ3.8102.090+1.720
TTM3.8102.091+1.719
YOY2.6862.881-0.195
5Y7.1683.545+3.623
10Y5.9283.936+1.992
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Alpine Immune Sciences Inc.

3.1. Institutions holding Alpine Immune Sciences Inc

Institutions are holding 95.864% of the shares of Alpine Immune Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Decheng Capital LLC10.806637.7199708328870832880
2023-12-31RA Capital Management, LLC7.49051.461649097632185854.6595
2023-12-31Great Point Partners LLC5.650112.0307370343362480020.2947
2023-12-31Paradigm Biocapital Advisors LP4.84662.8348317674375500031.1759
2023-12-31BlackRock Inc4.66620.0015305849870658130.0428
2023-12-31Cormorant Asset Management, LLC3.89042.3212255000065000034.2105
2023-12-31Orbimed Advisors, LLC3.86790.9652535245-1546347-37.8859
2023-12-31Vanguard Group Inc3.40950.0009223476775988851.5221
2023-12-31T. Rowe Price Associates, Inc.2.57420.0043168727829083420.8268
2023-12-31COMMODORE CAPITAL LP2.45632.6813161000028500021.5094
2023-12-31State Street Corporation2.12070.00131390029784484129.5501
2023-12-31Franklin Resources Inc1.86180.0109122033312203330
2023-12-31Woodline Partners LP1.52580.20731000106-38671-3.7227
2023-12-31Vivo Capital, LLC1.24991.2786819275-95638-10.4532
2023-12-31Geode Capital Management, LLC1.16610.001576434713542221.5323
2023-09-30Octagon Capital Advisors LP1.14421.319375000000
2023-12-31Morgan Stanley - Brokerage Accounts1.09650.00127187416652681244.1195
2023-12-31Adage Capital Partners Gp LLC1.09020.02827145907145900
2023-12-31HHG PLC0.88980.00665832395832390
2023-12-31Ikarian Capital, LLC0.74340.86964872484872480
Total 62.546763.745740996923+14283904+34.8%

3.2. Funds holding Alpine Immune Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31SPDR® S&P Biotech ETF2.99821.02611965208104720.5357
2024-03-31Vanguard Total Stock Mkt Idx Inv2.40070.0039157358730225823.775
2024-03-31US Small-Cap Growth II Equity Comp2.0850.2146136660626086923.5923
2024-03-31T. Rowe Price New Horizons2.0850.2146136660626086923.5923
2024-03-28iShares Russell 2000 ETF1.43590.0579411964530.0482
2024-03-31Franklin Biotechnology Discv A(acc)USD1.08811.583471320000
2024-03-31T. Rowe Price Health Sciences1.07430.1811704161490861230.1271
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr1.03310.02556771499611416.5419
2024-02-29Candriam Eqs L Biotech C USD Cap0.74761.0549000000
2024-03-31Franklin Biotechnology Discovery A0.56981.5585373474-13900-3.5883
2024-03-28iShares Biotechnology ETF0.51290.174633617800
2024-01-31Fidelity Small Cap Index0.50270.035432953347481.4619
2024-03-31T. Rowe Price New Horizons Tr-Z0.40650.21772664689023151.1987
2024-02-29TIAA-CREF Quant Small-Cap Equity Instl0.38820.285625446051302.0575
2024-03-31T. Rowe Price Integrated US Sm Gr Eq0.38220.11722505002505000
2024-03-31Direxion Daily S&P Biotech Bull 3X ETF0.3580.7447234625-1646-0.6967
2024-03-31State St Russell Sm/Mid Cp® Indx NL Cl C0.35760.02152344033390016.9075
2024-02-29Fidelity Extended Market Index0.34060.020522325230021.363
2024-02-29Fidelity Select Biotechnology0.33690.158222080000
2024-03-31Invesco Dorsey Wright SmallCap Momt ETF0.33580.753622009200
Total 19.43918.443712741498+1793861+14.1%

3.3. Insider Transactions

Insiders are holding 4.644% of the shares of Alpine Immune Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-25James N TopperSELL1964.57
2024-01-25James Paul RickeySELL23622
2023-12-27Mitchell GoldSELL2957320.04
2023-12-27Peter A ThompsonSELL18149819.96
2023-12-22Mitchell GoldSELL3782520.43
2023-12-19Mitchell GoldSELL240220.01
2023-12-18James Paul RickeySELL180019
2023-12-14James Paul RickeySELL1160019
2023-12-12Mitchell GoldSELL4106317.32
2023-12-08Mitchell GoldSELL806717.08
2023-12-05James Paul RickeySELL41816.01
2023-11-30James Paul RickeySELL70016
2023-11-06James Paul RickeySELL1800316.03

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Alpine Immune Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.2652.2650%0.893+154%0.864+162%0.639+254%
Book Value Per Share--5.0025.0020%2.737+83%2.196+128%1.474+239%
Current Ratio--7.8627.8620%4.155+89%4.449+77%11.350-31%
Debt To Asset Ratio--0.1410.1410%0.374-62%0.413-66%0.403-65%
Debt To Equity Ratio--0.1640.1640%0.598-73%0.806-80%0.451-64%
Dividend Per Share----0%-0%-0%-0%
Eps---0.491-0.4910%-0.881+79%-0.641+31%-0.493+0%
Free Cash Flow Per Share---1.213-1.2130%-0.674-44%-0.445-63%-0.385-68%
Free Cash Flow To Equity Per Share--1.3061.3060%0.893+46%0.940+39%0.555+135%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---7.732--------
Intrinsic Value_10Y_min---25.646--------
Intrinsic Value_1Y_max---0.470--------
Intrinsic Value_1Y_min---1.189--------
Intrinsic Value_3Y_max---1.644--------
Intrinsic Value_3Y_min---4.789--------
Intrinsic Value_5Y_max---3.099--------
Intrinsic Value_5Y_min---9.696--------
Market Cap4235208300.000+70%1249583130.0001249583130.0000%481869675.000+159%743456070.000+68%534711438.000+134%
Net Profit Margin---0.547-0.5470%-1.921+251%-6.411+1073%-14.535+2559%
Operating Margin---0.752-0.7520%-1.934+157%-6.587+776%-14.929+1886%
Operating Ratio--1.7521.7520%2.954-41%12.299-86%23.056-92%
Pb Ratio12.915+70%3.8103.8100%2.686+42%7.168-47%5.928-36%
Pe Ratio-131.594-239%-38.826-38.8260%-8.342-79%-20.158-48%-22.865-41%
Price Per Share64.600+70%19.06019.0600%7.350+159%11.340+68%8.156+134%
Price To Free Cash Flow Ratio-53.274-239%-15.718-15.7180%-10.910-31%-12.894-18%-14.734-6%
Price To Total Gains Ratio28.516+70%8.4148.4140%8.235+2%8.145+3%7.205+17%
Quick Ratio--14.57014.5700%7.977+83%7.687+90%19.201-24%
Return On Assets---0.084-0.0840%-0.201+139%-0.293+247%-0.351+317%
Return On Equity---0.098-0.0980%-0.322+228%-0.546+456%-0.449+357%
Total Gains Per Share--2.2652.2650%0.893+154%0.864+162%0.639+254%
Usd Book Value--327941000.000327941000.0000%179420000.000+83%143979200.000+128%96657767.600+239%
Usd Book Value Change Per Share--2.2652.2650%0.893+154%0.864+162%0.639+254%
Usd Book Value Per Share--5.0025.0020%2.737+83%2.196+128%1.474+239%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.491-0.4910%-0.881+79%-0.641+31%-0.493+0%
Usd Free Cash Flow---79499000.000-79499000.0000%-44166000.000-44%-29183200.000-63%-25219692.400-68%
Usd Free Cash Flow Per Share---1.213-1.2130%-0.674-44%-0.445-63%-0.385-68%
Usd Free Cash Flow To Equity Per Share--1.3061.3060%0.893+46%0.940+39%0.555+135%
Usd Market Cap4235208300.000+70%1249583130.0001249583130.0000%481869675.000+159%743456070.000+68%534711438.000+134%
Usd Price Per Share64.600+70%19.06019.0600%7.350+159%11.340+68%8.156+134%
Usd Profit---32183999.000-32183999.0000%-57762000.000+79%-42150599.800+31%-32434001.100+1%
Usd Revenue--58876000.00058876000.0000%30064000.000+96%24691600.000+138%12933600.000+355%
Usd Total Gains Per Share--2.2652.2650%0.893+154%0.864+162%0.639+254%
 EOD+6 -2MRQTTM+0 -0YOY+28 -55Y+29 -410Y+27 -6

4.2. Fundamental Score

Let's check the fundamental score of Alpine Immune Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-131.594
Price to Book Ratio (EOD)Between0-112.915
Net Profit Margin (MRQ)Greater than0-0.547
Operating Margin (MRQ)Greater than0-0.752
Quick Ratio (MRQ)Greater than114.570
Current Ratio (MRQ)Greater than17.862
Debt to Asset Ratio (MRQ)Less than10.141
Debt to Equity Ratio (MRQ)Less than10.164
Return on Equity (MRQ)Greater than0.15-0.098
Return on Assets (MRQ)Greater than0.05-0.084
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Alpine Immune Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5082.745
Ma 20Greater thanMa 5058.133
Ma 50Greater thanMa 10045.413
Ma 100Greater thanMa 20033.804
OpenGreater thanClose64.630
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets381,812
Total Liabilities53,871
Total Stockholder Equity327,941
 As reported
Total Liabilities 53,871
Total Stockholder Equity+ 327,941
Total Assets = 381,812

Assets

Total Assets381,812
Total Current Assets330,034
Long-term Assets51,778
Total Current Assets
Cash And Cash Equivalents 43,921
Short-term Investments 283,491
Net Receivables 749
Other Current Assets 1,873
Total Current Assets  (as reported)330,034
Total Current Assets  (calculated)330,034
+/-0
Long-term Assets
Property Plant Equipment 8,994
Long Term Investments 40,556
Long-term Assets Other 268
Long-term Assets  (as reported)51,778
Long-term Assets  (calculated)49,818
+/- 1,960

Liabilities & Shareholders' Equity

Total Current Liabilities41,980
Long-term Liabilities11,891
Total Stockholder Equity327,941
Total Current Liabilities
Short-term Debt 912
Accounts payable 3,593
Other Current Liabilities 21,187
Total Current Liabilities  (as reported)41,980
Total Current Liabilities  (calculated)25,692
+/- 16,288
Long-term Liabilities
Capital Lease Obligations 9,914
Long-term Liabilities  (as reported)11,891
Long-term Liabilities  (calculated)9,914
+/- 1,977
Total Stockholder Equity
Common Stock60
Retained Earnings -256,145
Accumulated Other Comprehensive Income 397
Other Stockholders Equity 583,629
Total Stockholder Equity (as reported)327,941
Total Stockholder Equity (calculated)327,941
+/-0
Other
Capital Stock60
Cash and Short Term Investments 327,412
Common Stock Shares Outstanding 50,000
Current Deferred Revenue16,288
Liabilities and Stockholders Equity 381,812
Net Debt -34,007
Net Invested Capital 327,941
Net Working Capital 288,054
Property Plant and Equipment Gross 11,827
Short Long Term Debt Total 9,914



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
0
4,134
28,543
87,909
61,935
85,222
54,873
54,093
144,090
255,900
286,686
381,812
381,812286,686255,900144,09054,09354,87385,22261,93587,90928,5434,1340
   > Total Current Assets 
0
1,803
28,442
87,686
61,663
82,548
53,545
42,302
107,101
192,013
240,993
330,034
330,034240,993192,013107,10142,30253,54582,54861,66387,68628,4421,8030
       Cash And Cash Equivalents 
0
1,098
27,812
24,991
24,203
8,000
10,711
16,123
34,959
67,907
13,376
43,921
43,92113,37667,90734,95916,12310,7118,00024,20324,99127,8121,0980
       Short-term Investments 
0
0
0
62,263
36,832
73,240
41,592
24,397
70,622
94,396
224,265
283,491
283,491224,26594,39670,62224,39741,59273,24036,83262,263000
       Net Receivables 
0
0
0
0
0
128
237
686
388
25,323
709
749
74970925,32338868623712800000
       Other Current Assets 
0
251
630
432
628
1,180
1,005
1,782
1,520
4,710
2,960
1,873
1,8732,9604,7101,5201,7821,0051,1806284326302510
   > Long-term Assets 
0
2,332
101
223
272
2,674
1,328
11,791
36,989
63,887
45,693
51,778
51,77845,69363,88736,98911,7911,3282,6742722231012,3320
       Property Plant Equipment 
0
175
91
213
175
1,089
1,196
11,537
11,186
10,553
9,803
8,994
8,9949,80310,55311,18611,5371,1961,089175213911750
       Long Term Investments 
0
0
0
0
0
0
0
0
25,549
52,866
35,481
40,556
40,55635,48152,86625,54900000000
       Intangible Assets 
0
0
0
0
0
1,453
0
0
0
0
0
0
0000001,45300000
       Other Assets 
0
0
10
0
0
132
132
254
35,204
4,964
409
0
04094,96435,204254132132001000
> Total Liabilities 
0
95,422
44,296
4,419
6,499
6,305
10,282
24,619
81,932
134,997
107,266
53,871
53,871107,266134,99781,93224,61910,2826,3056,4994,41944,29695,4220
   > Total Current Liabilities 
0
4,012
2,415
4,419
6,499
1,895
8,127
8,681
41,167
69,778
57,996
41,980
41,98057,99669,77841,1678,6818,1271,8956,4994,4192,4154,0120
       Short-term Debt 
0
1,994
0
0
-2,008
995
2,048
418
3,181
5,239
4,136
912
9124,1365,2393,1814182,048995-2,008001,9940
       Short Long Term Debt 
0
0
0
0
113
995
2,048
418
2,526
4,622
3,380
0
03,3804,6222,5264182,0489951130000
       Accounts payable 
0
671
929
994
1,921
193
1,716
1,543
582
3,349
4,286
3,593
3,5934,2863,3495821,5431,7161931,9219949296710
       Other Current Liabilities 
0
1,347
1,486
3,425
2,570
430
4,363
5,285
5,777
9,417
14,003
21,187
21,18714,0039,4175,7775,2854,3634302,5703,4251,4861,3470
   > Long-term Liabilities 
0
91,411
41,880
0
113
4,410
2,155
15,938
40,765
65,219
49,270
11,891
11,89149,27065,21940,76515,9382,1554,410113041,88091,4110
       Long term Debt Total 
0
0
0
0
0
4,039
2,155
4,509
7,602
3,380
0
0
003,3807,6024,5092,1554,03900000
       Other Liabilities 
0
0
0
2,008
0
371
0
0
21,348
50,830
39,185
0
039,18550,83021,3480037102,008000
       Deferred Long Term Liability 
0
0
0
0
0
371
0
0
0
0
0
0
00000037100000
> Total Stockholder Equity
0
-91,288
-15,752
83,490
55,436
78,917
44,591
29,474
62,158
120,903
179,420
327,941
327,941179,420120,90362,15829,47444,59178,91755,43683,490-15,752-91,2880
   Common Stock
0
0
2
15
16
14
14
19
24
30
46
60
604630241914141615200
   Retained Earnings Total Equity0-223,961-166,199-115,866-87,926-46,074-9,384-180,300-148,837000
   Accumulated Other Comprehensive Income 
0
-1,336
-1,401
3
-17
-59
-13
10
53
-273
-1,121
397
397-1,121-2735310-13-59-173-1,401-1,3360
   Capital Surplus 
0
0
110,265
232,309
235,737
88,346
90,664
117,371
177,947
287,345
404,456
0
0404,456287,345177,947117,37190,66488,346235,737232,309110,26500
   Treasury Stock000000-50,46700000
   Other Stockholders Equity 
0
21,029
111,666
231,699
224,202
3,124
35,791
117,371
177,947
287,345
404,456
583,629
583,629404,456287,345177,947117,37135,7913,124224,202231,699111,66621,0290



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue58,876
Cost of Revenue-576
Gross Profit58,30058,300
 
Operating Income (+$)
Gross Profit58,300
Operating Expense-102,550
Operating Income-44,250-44,250
 
Operating Expense (+$)
Research Development80,328
Selling General Administrative22,222
Selling And Marketing Expenses0
Operating Expense102,550102,550
 
Net Interest Income (+$)
Interest Income10,002
Interest Expense-98
Other Finance Cost-87
Net Interest Income9,817
 
Pretax Income (+$)
Operating Income-44,250
Net Interest Income9,817
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-32,081-56,419
EBIT - interestExpense = -44,348
-32,081
-32,086
Interest Expense98
Earnings Before Interest and Taxes (EBIT)-44,250-31,983
Earnings Before Interest and Taxes (EBITDA)-43,674
 
After tax Income (+$)
Income Before Tax-32,081
Tax Provision-548
Net Income From Continuing Ops-57,008-32,629
Net Income-32,184
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses103,126
Total Other Income/Expenses Net12,169-9,817
 

Technical Analysis of Alpine Immune Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alpine Immune Sciences Inc. The general trend of Alpine Immune Sciences Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alpine Immune Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alpine Immune Sciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 64.57 > 42.88 > 41.16.

Tweet this
Alpine Immune Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alpine Immune Sciences Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alpine Immune Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alpine Immune Sciences Inc. The current macd is 6.4502703.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alpine Immune Sciences Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alpine Immune Sciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alpine Immune Sciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Alpine Immune Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAlpine Immune Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alpine Immune Sciences Inc. The current adx is 57.95.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alpine Immune Sciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Alpine Immune Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alpine Immune Sciences Inc. The current sar is 55.12.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Alpine Immune Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alpine Immune Sciences Inc. The current rsi is 82.75. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Alpine Immune Sciences Inc Daily Relative Strength Index (RSI) ChartAlpine Immune Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alpine Immune Sciences Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alpine Immune Sciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Alpine Immune Sciences Inc Daily Stochastic Oscillator ChartAlpine Immune Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alpine Immune Sciences Inc. The current cci is 45.09.

Alpine Immune Sciences Inc Daily Commodity Channel Index (CCI) ChartAlpine Immune Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alpine Immune Sciences Inc. The current cmo is 71.57.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Alpine Immune Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartAlpine Immune Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alpine Immune Sciences Inc. The current willr is -31.57894737.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Alpine Immune Sciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Alpine Immune Sciences Inc Daily Williams %R ChartAlpine Immune Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alpine Immune Sciences Inc.

Alpine Immune Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alpine Immune Sciences Inc. The current atr is 1.56941176.

Alpine Immune Sciences Inc Daily Average True Range (ATR) ChartAlpine Immune Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alpine Immune Sciences Inc. The current obv is 96,876,992.

Alpine Immune Sciences Inc Daily On-Balance Volume (OBV) ChartAlpine Immune Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alpine Immune Sciences Inc. The current mfi is 69.06.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Alpine Immune Sciences Inc Daily Money Flow Index (MFI) ChartAlpine Immune Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alpine Immune Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Alpine Immune Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alpine Immune Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5082.745
Ma 20Greater thanMa 5058.133
Ma 50Greater thanMa 10045.413
Ma 100Greater thanMa 20033.804
OpenGreater thanClose64.630
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Alpine Immune Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Alpine Immune Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alpine Immune Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alpine Immune Sciences Inc

I send you an email if I find something interesting about Alpine Immune Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Alpine Immune Sciences Inc.

Receive notifications about Alpine Immune Sciences Inc in your mailbox!